Bridgebio Pharma Inc (BBIO)

Cash & Equivalents

$677.91M

Quarterly · Period ending: · USD

BBIO logo

BBIO Cash & Equivalents

Latest reported$677.91M
BBIO Quarterly Cash & Equivalents (-$92.00M → $677.91M)
High-resolution chart · PNG

BBIO cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
677,911,000
879,891,000
570,119,000
642,951,000
749,402,000
540,599,000
681,101,000
266,324,000
547,367,000
475,353,000
375,935,000
505,213,000
302,438,000
432,871,000
376,689,000
483,235,000
470,098,000
371,550,000
393,772,000
180,347,000
378,596,000
471,176,000
356,082,000
366,967,000
540,919,000
757,049,000
363,773,000
413,973,000
293,803,000
373,027,000
436,086,000
-91,995,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.